Finance

Beta
Lists
INTI:OTCMKTS
Inhibitor Therapeutics Inc
$0.085
0.00%
(0.00) 1D
Jun 8, 12:27:29 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTI...
Mkt. cap
14.64M
Avg. vol.
12.70K
Volume
0.00
52-wk high
$0.12
52-wk low
$0.04
EPS
-$0.02
Beta
-0.22
Shares outstanding
172.57M
No. of employees
5
Mkt. cap
14.64M
Avg. vol.
12.70K
Volume
0.00
52-wk high
$0.12
52-wk low
$0.04
EPS
-$0.02
Beta
-0.22
Shares outstanding
172.57M
No. of employees
5
News stories
From sources across the web
About Inhibitor Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteinhibitortx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
325.62K
377.79K
757.25K
340.56K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
370.15K
363.43K
557.87K
355.07K
Operating expense
695.77K
741.22K
1.32M
695.63K
Total operating expenses
695.77K
741.22K
1.32M
695.63K
Operating income
-695.77K
-741.22K
-1.32M
-695.63K
Other non operating income
-
-
-
-
EBT including unusual items
-659.94K
-712.18K
-1.30M
-686.42K
EBT excluding unusual items
-659.94K
-712.18K
-1.30M
-686.42K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-659.94K
-712.18K
-1.30M
-686.42K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
35.83K
29.03K
19.75K
9.21K
Interest expense
-
-
-
-
Net interest expenses
35.83K
29.03K
19.75K
9.21K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer